Hyundai Glovis Co. will establish a logistics center at Incheon International Airport to act as a multimodal transport warehouse covering seaborne and airborne cargo.
The logistics center will serve as a headquarters covering global airborne logistics via a connection with other bases.
To be completed in 2025, it would have a floor space of 46,111 square meters and five above-ground floors.
Hyundai Glovis will deal with global e-commerce cargo using a special cargo handling terminal with a classification system and customs clearance system.
The company will actively utilize smart and automated logistics facilities, including logistics robots developed by the U.robotics startup Boston Dynamics, which was recently acquired by Hyundai Motor Group.


Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Instagram Outage Disrupts Thousands of U.S. Users
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Thailand Inflation Remains Negative for 10th Straight Month in January
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



